Kymera Therapeutics Inc. – Indentures

NASDAQ: KYMR
Share price (9/25/26): $111.95
Market cap (9/25/26): $9.309 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from 8-K 13 pages Kymera Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock

from S-3ASR 35 pages Kymera Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities

from S-3ASR 35 pages Kymera Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities

from 8-K 13 pages Kymera Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock

from 8-K 13 pages Kymera Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock

from 8-K 13 pages Kymera Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock

from S-3ASR 39 pages Kymera Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities

from S-3ASR 39 pages Kymera Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities

from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended

from S-1/A 2 pages Indenture or similar

from S-1 36 pages Second Amended and Restated Investors’ Rights Agreement

from DRS 36 pages Second Amended and Restated Investors’ Rights Agreement